Profile | GDS2987 / GI_27885012-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 8.9 | 31 |
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | 11.6 | 37 |
GSM215254 | HMVEC_atorvastatin_rep1 | 27.8 | 56 |
GSM215282 | HMVEC_atorvastatin_rep3 | 4.4 | 11 |
GSM215344 | HMVEC_atorvastatin_rep2 | 33.4 | 60 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 3.8 | 8 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 26.9 | 47 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 15.9 | 26 |
GSM215294 | HMVEC_SLx2119_rep1 | 5.3 | 20 |
GSM215295 | HMVEC_SLx2119_rep2 | 8.7 | 18 |
GSM215296 | HMVEC_SLx2119_rep3 | 22.2 | 36 |
GSM215297 | PASMC_vehicle_rep1 | 41.4 | 53 |
GSM215298 | PASMC_vehicle_rep2 | 26.8 | 39 |
GSM215310 | PASMC_vehicle_rep3 | 14.7 | 24 |
GSM215311 | PASMC_atorvastatin_rep1 | 23.6 | 39 |
GSM215312 | PASMC_atorvastatin_rep2 | 37.3 | 51 |
GSM215313 | PASMC_atorvastatin_rep3 | 32.3 | 44 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 43.5 | 57 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 18.7 | 35 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 0.6 | 1 |
GSM215327 | PASMC_SLx2119_rep1 | 34.1 | 51 |
GSM215328 | PASMC_SLx2119_rep2 | 10.9 | 21 |
GSM215329 | PASMC_SLx2119_rep3 | 34.1 | 53 |
GSM215330 | Fibroblasts_vehicle_rep1 | 9.8 | 23 |
GSM215331 | Fibroblasts_vehicle_rep2 | 19.3 | 47 |
GSM215332 | Fibroblasts_vehicle_rep3 | 6.1 | 21 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 8.6 | 23 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 7.5 | 21 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 11.2 | 28 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 5.4 | 18 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 10.1 | 32 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 13.8 | 37 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 1.6 | 5 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 25.6 | 56 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 17.1 | 40 |